Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Arcosa Narrows FY2025 Sales Guidance from $2.850B-$2.950B to $2.860B-$2.910B vs $2.869B Est

Author: Benzinga Newsdesk | October 30, 2025 04:11pm
Arcosa (NYSE:ACA) narrows FY2025 sales outlook from $2.850 billion-$2.950 billion to $2.860 billion-$2.910 billion vs $2.869 billion estimate.

Posted In: ACA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist